Malignant neoplasms are one of the main causes of death and disability in the population of developed, and in recent years, developing countries. A significant loss of working capacity of a part of the population associated with this morbidity takes it beyond the scope of a purely medical problem. The annual steady increase in the absolute number of patients with a diagnosis of a malignant neoplasm established for the first time in their life is due to an improvement in diagnosis and registration, an increase in the number of older people, and a true increase in the incidence of a number of nosological groups.

The purpose of the study was to compare data on the cancer incidence rates for 2016 between the official reports on cancer statistics and federal cancer registry, collected in December 2018.Material and Methods. The study estimated the total data on 18 parameters from 35 regions of Russia, covering 66.3 million people (2016). The database of the Russian cancer registry and the database containing reports on the state cancer statistics were used. The cancer statistics/cancer registry ratio was assessed.Results. No differences in cancer incidence between the official reports on cancer statistics and cancer registry data were found. In the official reports on cancer statistics, the mortality rate, the proportion of posthumously recorded patients per 100 newly diagnosed, the proportion of deaths from diseases not related to cancer per 100 deceased patients, the cancer prevalence and the prevalence rate of unspecified malignant tumors were slightly reduced (to 10 %, 9 %, 5 %, and 4 %, respectively), and the rate of cancer detection, the proportion of histologically verified diagnoses and the proportion of cancers detected in stage III were increased (to 19 %, 10 % and 14 %, respectively) compared to those in cancer registry data.Conclusion. Improvement in the quality and completeness of information about cancer patients is associated rather with increasing the annual report length than with the need to improve the cancer registration system itself.

In this review we continue the publication of data on the problem of malignant neoplasms (MN) associated with human papillomavirus (HPV), in Russia. In a previous publication (Research’n Practical Medicine Journal 2016; 3(1): 66–78. DOI: 10.17709/2409-2231-2016-3-1-9) we at the first time presented the data on the incidence of malignant tumors associated with HPV in the Russian Federation for the period from 2009 to 2014. This article presents updated data on the incidence of in 2015, as well as data on mortality from the MN associated with HPV in Russia with the analysis of trends in men and women in different age groups. The statistics used in the article is calculated according to the annual state reporting documentation of the statistical form of the Ministry of health No. 7 and No. 35, forms 5 and Rosstat data, the combined database of the state of the cancer register of the Russian Federation.

In the P. Hertsen MORI we developed a methodological platform for the formation of the register of cancer patients, on the basis of which created information-analytical system cancer registry (RR RF) IAS Cancer registry, which is a multi-level system, including Federal and territorial segments. Territorial one is designed to monitor MN in the given subject of the Russian Federation (territorial population cancer registry). In Federal one we accumulate non-personally identifiable data territorial cancer registries Oncology clinics of the Russian Federation. As at 31 December 2015 BD PP of Russian Federation contains more than 5.1 million patients with malignant neoplasms (records of patients with diagnoses C00-D09 (ICD10)) from 45 subjects of the Russian Federation.

It is presented the comparative assessment of the quality of the records of patients who died from malignant neoplasms (MN), according to the report of Rosstat used to calculate mortality rates (form No. 5 “the Distribution of deaths by sex, age groups and causes of death”), and according to the report of the Ministry of health (form № 35 “Data on patients with malignant neoplasms”), used to calculate the mortality rate of patients under medical observation. Improving the quality and completeness of information about cancer patients is associated not only with the necessity of improving the accounting system, but with a best option compared with the most used in the world practice, as with any organizational issues.The following materials will be used. Rosstat data:• the distribution of deaths from MN by age and sex (form No. 5);• average annual number of population in administrative territories of Russia. The data of the Ministry of health (form No. 35):• the number of deaths from the MN from the number taken into account;• the number of deaths from the MN, not consisting on the account of cancer institution, including:– with the diagnosis established postmortem, including autopsy;– consisted on the account in medical institutions of other ministries and departments;• the number of deaths (from those considered), the cause of death was non-oncological disease;• the number of deaths from complications related to the treatment (from the number registered during the previous year and died from the MN).The study was conducted with the use of information and analytical support of the database on Oncology on the basis of state statistical reporting, created by P. Herzen MORI.